| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000003912 |
| Receipt No. | R000004678 |
| Official scientific title of the study | Randomized Controlled Trial of Carvedilol versus Rabeprazol Administration in the prevention of Esophageal Variceal Bleeding After Esophageal Variceal Ligation |
| Date of disclosure of the study information | 2010/07/15 |
| Last modified on | 2017/08/16 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | Randomized Controlled Trial of Carvedilol versus Rabeprazol Administration in the prevention of Esophageal Variceal Bleeding After Esophageal Variceal Ligation | |
| Title of the study (Brief title) | Post-EVL Trial | |
| Region |
|
|
| Condition | |||
| Condition | Patients after esophageal variceal ligation (EVL) | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The aim of this study is to compare the carvedilol therapy versus rabeprazol in the prevention of esophageal variceal bleeding after EVL. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | Phase III |
| Assessment | |
| Primary outcomes | Non-bleeding survival time |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Carbedilol | |
| Interventions/Control_2 | Rabeprazol | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1)Liver cirrhosis, Child A or B.
(2)Esophageal variceal ligation within three months. (3)Systolic blood pressure is more than 130 mm Hg or dyastolic blood pressure in more than 80 mm Hg. (4)Heart rate is more than 60 bpm. |
|||
| Key exclusion criteria | (1)Hepatocellular carcinoma
(2)Refractory ascites and uncontrolled hepatic encephalopathy (3)Active alcoholism before 3 months (4)Portal thrombus (5)Severe hypertension:Systolic pressure is more than 160 mm Hg or diastolic pressure is more than 100 mm Hg. (6)Contraindication for B-blockers (7)Pregnancy |
|||
| Target sample size | 400 | |||
| Research contact person | |
| Name of lead principal investigator | Hisashi Hidaka |
| Organization | Kitasato University East Hospital |
| Division name | Department of Gastroenterology, Internal Medicine |
| Address | 2-1-1 Asamizodai, Minami-ku, Sagamihara, Kanagawa 252-0380 |
| TEL | 81-42-748-9111 |
| hisashi7@kitasato-u.ac.jp | |
| Public contact | |
| Name of contact person | Hidaka Hisashi |
| Organization | Post-EVL Trial |
| Division name | Post-EVL Trial Office |
| Address | 2-1-1 Asamizodai, Minami-ku, Sagamihara, Kanagawa 252-0380 |
| TEL | 042-748-9111 |
| Homepage URL | |
| hisashi7@kitasato-u.ac.jp | |
| Sponsor | |
| Institute | Post-EVL Trial Office |
| Institute | |
| Department | |
| Funding Source | |
| Organization | The Japanese Fundation for Research and Promotion of Endoscopy |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000004678 |